Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells

Por de Frias, Mercè, Iglesias-Serret, Daniel, Cosialls, Ana M., Coll-Mulet, Llorenç, Santidrián, Antonio F., González-Gironès, Diana M., de la Banda, Esmeralda, Pons, Gabriel, Gil, Joan
Publicado em 2009

Bcl-2(high) mantle cell lymphoma cells are sensitized to acadesine with ABT-199

Por Montraveta, Arnau, Xargay-Torrent, Sílvia, Rosich, Laia, López-Guerra, Mònica, Roldán, Jocabed, Rodríguez, Vanina, Lee-Vergés, Eriong, de Frías, Mercè, Campàs, Clara, Campo, Elias, Roué, Gaël, Colomer, Dolors
Publicado no Oncotarget (2015)

Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study

Por Van Den Neste, Eric, Cazin, Bruno, Janssens, Ann, González-Barca, Eva, Terol, María José, Levy, Vincent, Pérez de Oteyza, Jaime, Zachee, Pierre, Saunders, Andrew, de Frias, Mercè, Campàs, Clara
Publicado em 2012

Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma

Por Montraveta, Arnau, Xargay-Torrent, Sílvia, López-Guerra, Mónica, Rosich, Laia, Pérez-Galán, Patricia, Salaverria, Itziar, Beà, Silvia, Kalko, Susana G., de Frias, Mercè, Campàs, Clara, Roué, Gaël, Colomer, Dolors
Publicado em 2014